INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2026, Number 3

Cardiovasc Metab Sci 2026; 37 (3)

Should the battery of the implantable cardioverter defibrillator be changed or not, due to depletion and the fact that it has never been discharged?

Álvarez de la Cadena-Sillas, Jorge; Asensio-Lafuente, Enrique; Aguilar-Linares, Julio; Jiménez-Cruz, Marcelo

ABSTRACT

The use of Implantable Cardioverter Defibrillators (ICDs) has proven to be effective and useful to improve survival rates after Sudden Cardiac Death (SCD) in patients with clinical indications for their use. However, replacing a generator that has never administered electrical therapies and now shows battery depletion can generate controversy. In this paper, we analyze different factors that must be considered prior to the generator’s replacement in this subset of patients. The main points are improvement or not of the Left Ventricular Ejection Fraction (LVEF), risk re-stratification at the time of replacement, the presence or absence of inappropriate ICD therapies, the severity of the heart disease, the prognosis at the time of the substitution, present comorbidities, life expectancy and advancing age, the possible complications of the new procedure, the possibility of de-escalating the device, financial factors, as well as the patient’s own decision and the underlying clinical discussion.
  FULL TEXT PDF   FLIPBOOK

Keywords

implantable cardioverter defibrillator battery depletion generator replacement




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Mobile application to standardize and facilitate invasive hemodynamic...
    2026, Vol.37, Núm. 3
  • Is a meager budget for science and research compatible with a country’s...
    2026, Vol.37, Núm. 3
  • Characterization of clinical and anatomical profile of patients with anomalous...
    2026, Vol.37, Núm. 3
  • Ibogaine. A new nightmare for cardiologists in tourist cities?
    2026, Vol.37, Núm. 3
  • Should the battery of the implantable cardioverter defibrillator be changed or...
    2026, Vol.37, Núm. 3
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3


Cardiovascular and Metabolic Science Vol. 37, Num. 3, Julio-Septiembre 2026. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 http://www.medigraphic.com/cms ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-022717130200-102. ISSN impreso: 2683-2828, ISSN electrónico: 2954-3835. Otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 30 de septiembre de 2026.

 

2026     |     https://www.cardiovascularandmetabolicscience.org.mx/